The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical …
The use of electronic signatures is desirable for companies nowadays as technology has growingly become an integral part of our life. Not only that, implementing …
Academic publishing is highly competitive, and this competition is only growing as more and more research papers are being submitted to top journals – submissions …
Despite a disastrous commercial rollout, Biogen is still producing longer-term data for beleaguered Alzheimer’s disease therapy Aduhelm. In patients who’ve been treated with Aduhelm for …
Novo Nordisk takes a page from three popular TV genres—medical drama, ’90s sitcom and procedural crime show—by casting actress Queen Latifah in a new video …
Shiyan Caan of SQN Health examines the tools and services which provide the clinical trial market with the ability to adapt to a changing environment. …
About 5 years ago, Topeka man, Allen Davis started to experience symptoms of Alzheimer’s Disease and Dementia. Now he’s focused on one thing. “Hopefully it’s not getting …
The FDA recently finalized an eagerly awaited guidance on the incorporation of electronic health records and real-world data into clinical trials and product submissions, including …
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced …
According to ClinicalTrials.gov, device trials have increased 94 percent from 2012 to 2017. The medical device contract research organization (CRO) market is expected to continue …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
